local_hospital

Tallaght Adult Mental Health Service

Address
lock Available on a paid plan

Psychiatry and Psychology at Tallaght Adult Mental Health Service

The research activity here focuses on mental disorders within psychiatry and psychology, with studies centered on difficult-to-treat conditions such as treatment-resistant depression. These trials are designed to explore whether new therapy approaches can improve depressive symptoms and offer better options for people who have not responded well to standard care.

  • Evaluating a new treatment approach for treatment-resistant depression
  • Studying how psychological support may help improve depression outcomes

This work reflects an ongoing effort at the Adult Mental Health Services to expand treatment possibilities for complex mood disorders and better understand which interventions may bring meaningful symptom relief.

Trauma-Related Mental Health Research in Dublin

Another key area at this site is the study of post-traumatic stress disorder within the broader field of psychiatry. The research is aimed at assessing both the safety and potential benefit of a new oral therapy for people living with PTSD, with the goal of improving symptom control and quality of life.

  • Investigating a potential treatment for post-traumatic stress disorder
  • Assessing safety, tolerability, and symptom improvement in PTSD

At Tallaght Adult Mental Health Service, this trial work highlights a focused interest in trauma-related conditions and the search for more effective options for patients with persistent mental health symptoms.

Site Overview

assignment
7
connected trials
corporate_fare
5
sponsors
science
5
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
2
Trials started 6–12 months ago
7
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
5
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +1 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 45 other sites in Ireland

description
Trial volume
7
Outperforms 67% of sites
public
Therapeutic diversity
1areas
Outperforms 0% of sites
groups
Sponsor diversity
5sponsors
Outperforms 67% of sites

Therapeutic Area Benchmark — Ireland

Select a therapeutic area to compare against other sites in Ireland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Ireland

Market Share

Country: Ireland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Tallaght Adult Mental Health Service

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety of Psilocybin (COMP360) in Adults with Treatment-Resistant Depression: A Phase III Randomized, Double-Blind, Controlled TrialCompass Pathfinder LimitedPhase IIINot RecruitingFeb 2024

IMP list

lock Showing 1 of 5 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Methylone2Unknown2024-01-162024-06-13

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.